| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |